Physician profile
David J Casey
NPI 1437134442
$19,910.62
in general payments reported to CMS, 2019-2025
11 companies · $3,497 in 2025
The $3,497 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $25.32 · 2021: $170 · 2022: $1,520 · 2023: $9,275 · 2024: $4,943 · 2025: $3,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $3,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,435.18 |
| Food and Beverage | $3,278.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,389.00 | 2019-2025 | Mako, Ezout, 1788 |
| Smith+Nephew, INC. | $6,084.93 | 2020-2025 | Journey II, Ri Hip Navigation, Journey |
| Steris Corporation | $3,889.21 | 2023 | |
| Zimmer Biomet Holdings, INC. | $2,054.56 | 2019-2024 | Avenir, Persona, Rosa |
| Tricoast Surgical Solutions LLC | $1,137.82 | 2023 | |
| Depuy Synthes Sales INC. | $142.64 | 2019 | |
| Medtronic USA, INC. | $101.99 | 2019 | |
| Innovation Technologies INC | $49.13 | 2023 | Irrisept |
| Abbott Laboratories | $23.22 | 2024 | Eterna |
| Covidien LP | $20.12 | 2019 | |
| Arthrex, INC. | $18.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.